Australian Society of Antimicrobials
 
  Become a Member

 

ASA Travel Awards

ASA has made funds available for travel awards to assist Members wanting to attend the Society's annual scientific meeting. Awards are made to ASA financial members presenting a proffered paper (oral or poster) at the meeting.  Applicants must have current ASA membership and must have been ASA members for at least the last 12 months.   Recipients of  an Award are required to write a report on the meeting for the ASA Newsletter.  


The awards consists of a return economy airfare, accommodation and conference registration up to the value of AUD2,000. 


ASA members who wish to apply for this award are invited to submit their application to the ASA Secretary Denise Daley at info@asainc.net.au.  The application should include a copy of the abstract and for abstracts with more than one author, a letter stating the relative contribution of the applicant towards the research.


Antimicrobials 2017 ASA Travel Award Recipients

Adelaide Convention Centre, Adelaide, South Australia 

23 - 25 February 2017


Sarah Baines. The University of Melbourne, Victoria, Australia. Evolving chlorhexidine tolerance with a prevalent hospital lineage of methicillin-resistant Staphylococcus aureus

Kate Worthing.  University of Sydney, New South Wales, Australia. Characterisation of novel SCCmec elements from methicillin-resistant Staphylococcus pseudintermedius from Australian animals


Indy Sandaradura. Westmead Hospital, New South Wales, Australia. Computerised fluconazole dose selection in critical illness


Antimicrobials 2016 ASA Travel Award Recipients

Melbourne Convention Centre, Melbourne, Victoria

25 - 27 February 2016


Josh Ramsay. Curtin University, Western Australia, Australia. Resolving the enigma of methicillin-resistance transfer in Staphylococcus aureus

Edward Raby.  Fiona Stanley Hospital, Western Australi. Zoonotic transmission of the methicillin-resistant Staphylococcus aureus ST612-IV equine strain


Terence Lee. Murdoch University, Western Australia. The vancomycin LECOFF and vanB subtypes of E. faecium isolated in Australia

Antimicrobials 2015 ASA Travel Award Recipients
Brisbane Exhibition and Convention Centre, Brisbane Queensland

26 - 28 February 2015


Josh Ramsay.  Curtin University, Western Australia, Australia.  The Majority of Multidrug-resistance Plasmids in Staphylococcus aureus Carry Origin-of-Transfer Sequences that are Mobilisable by Conjugative Plasmids


Jason Kwong. University of Melbourne, Victoria, Australia. Whole Genome Sequencing Indicates Local Transmission of KPC-2 Producing Klebsiella pneumoniae in a Victoria-wide Outbreak


Sam Abraham. University of Adelaide, South Australia, Australia. First Detection of Extended-spectrum Cephalosporin and Fluoroquinolone-Resistant Pathogenic Escherichia coli in Australian Food-producing Animals, Representing Internationally Disseminated, Multidrug-resistant Zooanthroponotic Clonal Lineages


Antimicrobials 2014 ASA Travel Award Recipients
Melbourne Convention Centre, Melbourne, Victoria

20 - 22 February 2014


Janet Montgomery.  Austin Health, Victoria, Australia.  Phenotypic Detection of Carbapenemase Producing Gram Negative Bacilli: Which Method is Better?


Wei Gao.  Austin Centre for Infection Research, Victoria, Australia.  Genomics of Persistent Staphylococcus aureus Infection.


Hanna  Sidjabat.  The University of Queensland Centre for Clinical Research, Queensland, Australia.  Increasing Emergence of IMP-4 Producing Enterobacteriaceae throughout Queensland Hospitals.


Elizabeth  Witherden.  University of Tasmania, Tasmania, Australia.  The Role of Inter-species Recombination of the ftsI Gene on the Dissemination of Altered Penicillin-binding Protein 3 Mediated Resistance in Haemophilus influenzae and Haemophilus haemolyticus.


Antimicrobials 2013 ASA Travel Award Recipients
Sofitel Sydney Wentworth, Sydney, New South Wales

21 - 23 February 2013


Natasha Holmes. Austin Centre for Infection Research, Austin Health, Victoria, Australia.  Development of Teicoplanin Resistance in vanB Vancomycin-Resistant Enterococcus faecium during Treatment for Infections in Solid Organ Transplant Recipients


Steven Tong. Menzies School of Health Research, Northern Territory, Australia.  Whole Genome Sequencing of ST239-MRSA and the Influence of Within-Host Clouds of Variation  


Margaret Lam. University of Melbourne, Victoria, Australia.  Using Genomics to Understand the Success of ST230 Vancomycin Resistant Enterococcus faecium 

{cke_protected_1}  

Antimicrobials 2012 ASA Travel Award Recipients
Brisbane Exhibition and Convention Centre, Brisbane Queensland

23 - 25 February 2012


Natasha Holmes. Austin Centre for Infection Research, Austin Health, Victoria. Searching for Organism Factors that may Explain the Association between Elevated Vancomycin Minimum Inhibitory Concentration and Mortality in Staphylococcus aureus Bacteraemia.

Kyra Chua. University of Melbourne, Victoria. Why is Australian Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) ST93-IV [2B] Highly Virulent?

Deborah Williamson. Auckland District Health Board, New Zealand. Sequence Type (ST) 131 Escherichia coli as a Major Cause of Bacteraemia Following Transrectal Ultrasound-guided Prostate Biopsy


Antimicrobials 2011 ASA Travel Award Recipients
Hilton on the Park, Melbourne Victoria

24 - 26 February 2011


Hanna Sidjabat. University of Queensland, Australia. Molecular Epidemiology of Cephalosporinase Encoding Plasmids in Escherichia coli


Andrew Bowen. Southern IML Pathology, Australia. Measurement Uncertainty and the CDS Method


Antimicrobials 2010 ASA Travel Award Recipients
Sofitel Sydney Wentworth Hotel, Sydney New South Wales
 

25 - 27 February 2010


Stephen Tristram. University of Tasmania, Australia. Screening and Identifying BLNAR and BLPACR Strains of H. influenzae.

 

Natasha Holmes. Austin Health, Australia. Vancomycin Minimum Inhibitory Concentration (MIC) in Australian Staphylococcus aureus Bactaeraemia (SAB) - An Australian and New Zealand Cooperative on Outcomes in Staphylococcal Sepsis (ANZCOSS) Substudy.

 

Steven Tong. Menzies School of Health Research, Northern Territory, Australia. Molecular Detection of the H275Y Oseltamivir Resistance Mutation in Influenza A/H1N1 2009 by Step-Down RT-PCR and SYBR Green High-Resolution Melting Analysis.   


Antimicrobials 2009 ASA Travel Award Recipients
Hilton on the Park, Melbourne Victoria
26 - 28 February 2009


Peter Huntington. Royal North Shore Hospital, Australia. An Agar Dilution Method for Detection of Metallo-beta-lactamase Producing Enterobacteriaceae, Pseudomonas and Acinetobacter.

 

Vicki McNeil. Department of Health, South Australian Government, Australia. Use of DU90% Method to Assess Antimicrobial Usage by National Antimicrobial Utilisation Surveillance Program (NAUSP) Contributors.

 

Lee Thomas. Westmead Hospital, New South Wales. A Comparison of Three Commercial Available Chromogenic Media for the Rapid Detection of MRSA.


Antimicrobials 2008 ASA Travel Award Recipients
Stamford Plaza Double Bay, Sydney New South Wales
21 - 23 February 2008


Catherine Bennett. University of Melbourne, Australia. More Common than we thought? Methicillin Resistance and PVL in Community-Onset Staphylococcus aureus Infections in Melbourne.

 

Janet Montgomery. Austin Hospital, Australia.  Comparison of Phenotypic Tests for Detection of Plasmid Mediated AmpC-Mediated Beta-lactamases.

  

Antimicrobials 2007 ASA Travel Award Recipients
Rydges Melbourne, Melbourne Victoria
22 - 24 February 2007


Steven Tong. Royal Darwin Hospital, Australia. Community-Associated Methicillin-
Resistant Staphylococcus aureus: A Prospective Case-Cohort Study in Northern
Australia.


Stephen Tristram. University of Tasmania, Australia. TEM-15 ESBL and Altered PBP3 in Multi-
Resistant Strains of Haemophilus influenzae.

Nicholas Biehl. University of Western Australia, Australia. Community-Onset MRSA Infection:
A Survey of Knowledge and Behaviour of Western Australian General Practitioners.


Antimicrobials 2006 ASA Travel Award Recipients
Crowne Plaza, Coogee Beach, Sydney NSW
23 - 25 February 2006


Kate Dollman. South Australia Department of Health, Australia. National Antimicrobial
Utilisation Surveillance.

Elizabeth Grabsch. Austin Health. Australia. Oxgall Supplement to Mueller-Hinton and Brain-
Heart Infusion Agar Improves the Routine Identification of Low-MIC Vancomycin-Resistant
Enterococci (LM-VRE).


Antimicrobials 2005 ASA Travel Award Recipients

Cumberland Lorne Resort, Lorne Victoria

24 - 26 February 2005


Sreeja Sudhakaran. Monash University. Australia. Inhibition of P-Glycoprotein Mediated
Efflux: A Mechanism to Increase Indinavir Transfer to the Foetus.

Matthew Rawlins, Royal Perth Hospital, Australia. Assessing the Impact of an Antimicrobial
Stewardship Programme Round at a WA Teaching Hospital.


Antimicrobials 2004 ASA Travel Award Recipients

Novotel Brighton-Le-Sands, Sydney NSW

26 - 28 February 2004


Frances O'Brien. Curtin University. Australia. Plasmid Encoded Fusidic Acid Resistance in Staphylococcus aureus


Tom Solano. Royal Prince Alfred Hospital. Australia. Comparison of Antibiotic Dispensing Data
Versus Administration Data in Intensive Care.

Stephen Tristram. University of Tasmania. Australia. Disc Diffusion Based Screening Tests for
Extended Spectrum Beta Lactamases in Haemophilus influenzae.

Sophia Tan.University of South Australia. Australia Macrolide, lincosamide and streptogramin
resistance in E.faecium



The ASA ISSSI Travel Scholarship 


ASA has made funds available for a travel scholarship to assist Members who are preferably a PhD student or an advanced trainee who will be presenting at the International Symposium on Staphylococci and Staphylococcal Infections (ISSSI).


The scholarship consists of return economy airfare, accommodation and conference registration up to the value of AU$5,000.
 
Applicants must have current ASA membership and must have been a member for at least the last 12 months.  The scholarship is restricted to Australian and New Zealand ASA financial members and is conditional upon the abstract being accepted by the ISSSI program committee for presentation (oral or poster).  In addition the recipient of the scholarship is required to write a report on the meeting for the ASA Newsletter.


Eligible ASA members who wish to apply for this scholarship are invited to submit their application to the ASA Secretary Denise Daley at info@asainc.net.au.  The application should include a copy of their abstract and for abstracts with more than one author, a letter stating the relative contribution of the applicant towards the research.

  

ISSSI 2014 Travel Scholarship Recipient

Chicago, USA

26 - 29 August 2014


Josh Ramsay. Curtin University. Australia. Conjugative Mobilisation of Diverse Antimicrobial-resistance and Virulence Gene Plasmids by the pWBG749 Family of Conjugative Plasmids


ISSSI 2012 Travel Scholarship Recipient

Lyon, France

26 - 30 August 2012


Wei Gao. Austin Hospital. Australia. Subtle Changes in Clinical Staphylococcus aureus Promote Co-resistance to Antimicrobials and Innate Immune Response


ISSSI 2010 Travel Scholarship Recipient

Bath, United Kingdom

6 - 9 September 2010


Kyra Chua. Austin Hospital. Australia. Understanding Increased Virulence of ST93-MRSA-IV, A Unique Australian Clone of Community Methicillin-Resistant Staphylococcus aureus"


The bioMerieux ASA Identifying Resistance Travel Award


This is awarded to an individual on the basis of a proffered paper (oral or poster) presented during the ASA's Annual Scientific Meeting dealing with the identification of antimicrobial resistance in a routine clinical setting.


The applicant must be a financial member of the ASA. The Award is restricted to ASA members residing in Australia or New Zealand.  The award committee will take into account the quality and originality of the paper.


The award consists of AU$1000 cash prize, a commemorative plaque, and the provisions of flights, accommodation and registration for the recipient to attend Antimicrobials 2016. The award committee will consist of three ASA committee members.


Antimicrobials 2017 bioMerieux ASA Identifying Resistance Travel Award Recipient

Adelaide Convention Centre, Adelaide

23 - 25 February 2017


Frances Hurren, Austin Hospital, Victoria

The Carbapenem Inactivation Method (CIM) for the Detection of OXA Enzymes in Gram-Negative Bacteria


Antimicrobials 2016 bioMerieux ASA Identifying Resistance Travel Award Recipient

Melbourne Convention Centre, Melbourne

25 - 27 February 2016


Nicola Townell, Sullivan Nicolaides, Queensland

Detection of Beta-lactam Resistance in Enterobacteriaceae using the MALDI-TOF MS


Antimicrobials 2015 bioMerieux ASA Identifying Resistance Travel Award Recipient

Brisbane Exhibition and Convention Centre, Brisbane

26 - 28 February 2015


Karen Lawry, Auckland District Health Board, New Zealand

Laboratory Detection of Carbapenemase-Producing Enterobacteriaceae: Evaluation of pheotypic and Molecular Methods


Antimicrobials 2014 bioMerieux ASA Identifying Resistance Travel Award Recipient

Melbourne Convention Centre, Melbourne

20 - 22 February 2014


Lai-Yang Lee, Monash Health, Victoria.

Rapid Time to Results for Carba NP Test from Early Culture Growth Associated with Improved Sensitivity for Detection of Carbapenemase Producers among Carbapenem Non-susceptible Gram-negative Bacilli


Antimicrobials 2013 bioMerieux ASA Identifying Resistance Travel Award Recipient

Sofitel Sydney Wentworth Hotel, Sydney

21 - 23 February 2013


Linda Joyce, St Vincents Hospital, Victoria.

Comparison of Direct Blood Culture Identification and Antibiotic Sensitivity Test Results with Confirmatory Result


Antimicrobials 2012 bioMerieux ASA Identifying Resistance Travel Award Recipient

Brisbane Exhibition and Convention Centre, Brisbane

23 - 25 February 2012

  

Hanna Sidjabat, University of Queensland Centre for Clinical Research, Queensland.

Development of Multiplex PCR: B-lactamase Genes and Viruelence Determinants in E.coli

 

Antimicrobials 2011 bioMerieux ASA Identifying Resistance Travel Award Recipient

 

Hilton on the Park, Victoria

24 - 26 February 2011

 

Susan Grima, Southern Cross Pathology. Australia.

Direct Antimicrobial Susceptibility Testing of Enterococci from Urine Samples

 

Antimicrobials 2010 bioMerieux ASA Identifying Resistance Travel Award Recipient

Sofitel Sydney Wenworth Hotel, Sydney

25 - 27 February 2010

  

Paul Ingram. PathWest Laboratory Medicine - WA (Sir Charles Gairdner Hospital)

Detection of AmpC Beta-lactamases Using a Novel Etest Strip 

 

Antimicrobials 2009 bioMerieux ASA Identifying Resistance Travel Award Recipient

Hilton on the Park, Victoria

26 - 28 February 2009

  

Justin Ellem, Westmead Hospital. Australia.

Comparison and Evaluation of a Newly Developed Mast 4-Disc Test for the Detection of Plasmid-Mediated AmpC Beta-lactamases

 

Antimicrobials 2008 bioMerieux ASA Identifying Resistance Travel Award Recipient

Stamford Double Bay, New South Wales

21 - 23 February 2008

 

Janet Montgomery, Austin Health. Australia.

Comparison of Phenotypic Tests for Detection of Plasmid-Mediated AmpC Beta-lactamases

    

Antimicrobials 2007 bioMerieux ASA Identifying Resistance Travel Award Recipient
Rydges Melbourne, Melbourne, Victoria

22 - 24 February 2007


Cheryll McCullough, PathWest Laboratory Medicine WA - Royal Perth Hospital, Australia.
Phenotypic Confirmation of Extended Spectrum B-lactamases in Enterobacteriacae Using
Commercially Prepared Diffusion Systems


Antimicrobials 2006 bioMerieux ASA Identifying Resistance Tracel Award Recipient
Crowne Plaza, Coogee Beach, Sydney NSW
23 - 25 February 2006

 

Jacqueline Schooneveldt, Queensland Health Pathology Services, Australia.
MRSA Screenung Using the Tube Coagulase on Selective Enrichment Broth and Real Time PCR
Versus Proprietary RT PCR (IDI-MRSA)


Antimicrobials 2005 bioMerieux ASA Identifying Resistance Travel Award Recipient
Cumberland Lorne Resort, Lorne Victoria
24 - 26 February 2005


Jacqueline Harper, Queensland Health Pathology Services, Australia.

Routine Tests for Detection of mecA-mediated Resistance in Staphylococcus aureus


Antimicrobials 2004 bioMerieux ASA Identifying Resistance Travel Award Recipient
Novotel Brighton-Le-Sands, Sydney NSW
26 - 28 February 2004


Janet Montgomery. Austin Health. Australia
Accuracy of Routine Detection of Oxacillin Resistance in Clinical Staphylococcus aureus


Antimicrobials 2003 bioMerieux ASA Identifying Resistance Travel Award Recipient
Hilton on the Park, Melbourne VIC

1 - 3 May 2003


Cheryll McCullough. Royal Perth Hospital, Australia
The Inability of NCCLS Disc Diffusion Oxacillin Interpretive Breakpoint for S aureus to Reliably Detect Oxacillin-Susceptible Staphylococcus lugdunensis

  


ASA AstraZeneca ECCMID Travel Award


ECCMID 2011 AstraZeneca Travel Award Recipient
Milan, Italy


Anton Peleg. Monash University, Australia.

A Novel Mechanism of Reduced Susceptibility to Vancomycin in Staphylococcus aureus


ASA AstraZeneca ICAAC Travel Award 


ICAAC 2010 AstraZeneca Travel Award Recipient
Boston, USA


Christopher Blyth. The University of Western Australia, Australia.

Bacterial and Viral Coinfections in Severe Influenza Infections 2009

  

ICAAC 2009 AstraZeneca Travel Award Recipient
San Francisco, USA


Douglas Johnson. Austin Hospital, Australia.

Neutralising Antibody Responses to a Recombinant Mammalian Cell Derived Hepatitis C (HCV) Virus Like particle Vaccine


ICAAC 2008 AstraZeneca Travel Award Recipient
Washington, USA


Anton Peleg. Beth Israel Deaconess Medical Centre, Boston, USA

Relationship between Virulence and Reduced Susceptibility to Daptomycin in Staphylococcus aureus

Galleria mellonella as a Model System to Study Acinetobacter baumannii Pathogenesis and Therapeutics


Catherine Bennett. The University of Melbourne, Australia

Patient and Infection Characteristics Associated with the Presence of pvl in Community Onset Staphylococcus aureus Infections in Melbourne, Australia


ICAAC 2007 AstraZeneca Travel Award Recipient
Chicago, USA


Julie Pearson. PathWest Laboratory Medicine WA - Royal Perth Hospital, Australia

Detection of International Panton-Valentine Leucocidin (PVL) Positive CA-MRSA Clones in Western Australia  


ICAAC 2006 AstraZeneca Travel Award Recipient
San Francisco, USA

  

Ben Howden. Austin Health, Australia
Whole Genome Comparison of a Vancomycin-Susceptible Staphylococcus aureus (VSSA) and a Vancomycin-Intermediate Derivative (VISA) Obtained from a Patient with Vancomycin Treatment Failure


ICAAC 2005 AstraZeneca Travel Award Recipient
Washington DC, USA


Jian Li. Monash University, Australia

In vitro Pharmacodynamics (PD) of Colistin and Colistin Methanesulfonate (CMS) agaianst Acinetobacter baumannii

 

ICAAC 2004 AstraZeneca Travel Award Recipient
Washington DC, USA


Ben Howden. Austin Health, Australia
Identification of a New Agar Dilution Screening Method for the Accurate Detection of Heterogenous-Vancomycin Intermediate Staphylococcus aureus (hVISA).


ICAAC 2003 AstraZeneca Travel Award Recipient
Chicago, USA


Sue Ballard. Austin Health, Australia
Correlating the Detection of vanB Genes in Faeces to the Presence of Vancomycin Resistant Enterococci (VRE): Interference by vanB containing Anaerobes


ICAAC 2002 AstraZeneca Travel Award Recipient
San Diego, USA


Ian Kay. Royal Perth Hospital, Australia
Performance of a Real-time Multiplex PCR Assay versus Culture for the Rapid Detection of vanA and vanB Genes Directly from Clinical Specimens